Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor: Results of a Single- and Multiple-Dose Study-Reference-Cited by-同舟云学术

Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor: Results of a Single- and Multiple-Dose Study

Published:2016-10-06 Issue:11 Volume:56 Page:1335-1343
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Agarwal Suresh K.¹,Hu Beibei¹,Chien David²,Wong Shekman L.¹,Salem Ahmed Hamed¹³

Affiliation:

1. Clinical Pharmacology and Pharmacometrics; AbbVie Inc; North Chicago IL USA

2. Oncology Development; AbbVie Inc; North Chicago IL USA

3. Clinical Pharmacy; Faculty of Pharmacy; Ain Shams University; Cairo Egypt

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Eichhorst;Ann Oncol,2015

2. Apoptosis inducers in chronic lymphocytic leukemia;Billard;Oncotarget,2014

3. The Bcl2 family: regulators of the cellular life-or-death switch;Cory;Nat Rev Cancer,2002

4. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions;Borner;Mol Immunol,2003

5. The Bcl-2 family: roles in cell survival and oncogenesis;Cory;Oncogene,2003

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecularly Imprinted Electrochemical Sensor for the Ultrasensitive and Selective Detection of Venetoclax;ACS Omega;2024-08-08

2. Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia;Cancer Chemotherapy and Pharmacology;2024-05-23

3. Evaluation and Optimization of a Microcavity Plate–Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates;Drug Metabolism and Disposition;2024-05-22

4. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling;Drug Metabolism and Disposition;2024-05-13

5. Population Pharmacokinetic Models of Venetoclax in Hematologic Malignancies: A Systematic Review;Drug Design, Development and Therapy;2024-05